S&P 500
5.469,30 +21,43 (+0,39%) Nasdaq
17.717,65 +220,84 (+1,26%) NIKKEI 225
39.653,22 +480,07 (+1,23%) Dólar/Euro
1,0712 -0,0003 (-0,03%) Petróleo Brent
85,38 +0,37 (+0,44%) Bitcoin EUR
57.631,63 +356,83 (+0,62%)
IceCure Medical Ltd (ICCM)
Después del cierre:
IceCure Medical Ltd
7 Ha’Eshel Street
PO Box 3163
Caesarea 3079504
Israel
972 4 623 0333
https://www.icecure-medical.com
Sector(es): Healthcare
Sector: Medical Devices
Empleados a tiempo completo: 71
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Eyal Shamir | CEO & Director | 416,36k | N/A | 1961 |
| Mr. Ronen Tsimerman CPA | CFO & COO | 306,4k | N/A | 1969 |
| Ms. Tlalit Bussi Tel-Tzure | Vice President of Business Development & Global Marketing | 248,44k | N/A | 1971 |
| Ms. Merav Nir Dotan | Vice President of Human Resources | 197,96k | N/A | 1969 |
| Ms. Galit Malik | Vice President of Operations & Service | N/A | N/A | 1973 |
Descripción
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
Gobierno corporativo
El ISS Governance QualityScore de IceCure Medical Ltd, a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.
